درباره این اپیزود
Cathy Campbell is the first diabetes technology specialist midwife in the UK working at the Leicester Diabetes Centre in a role only recently introduced post the NICE TA943 on Hybrid Closed Loop.
Cathy shares her expertise and insight on supporting people who are pregnant with type 1 or type 2 diabetes with Nic Taylor professional education specialist here at Dexcom UK & Ireland.
Learn more about why it is important to keep glucose levels within the advised ranges during pregnancy and how technology has a role to play in this. A great listen not only for those working in diabetes but anyone working in pregnancy services in the UK and Ireland.
If there is referral to pregnant women / ladies. This is not that we don’t acknowledge that some people we provide care for, don’t identify as women, but for the purpose of this podcast – the term women / ladies is used.
With / speaker;
Cathy Campbell, Diabetes Specialist Midwife (Technology), Leicester Diabetes Centre
*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
NICE. Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. Accessed July 2024. https://www.nice.org.uk/guidance/ta943†
NICE. Diabetes in pregnancy: management from preconception to the postnatal period. Accessed July, 2024. https://www.nice.org.uk/guidance/ng3 †
NHS England. Saving babies’ lives: version 3. Accessed July, 2024. https://www.england.nhs.uk/long-read/saving-babies-lives-version-3
† © NICE [2023]. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.
MAT-6487
Subscribe to be the first to listen to Season 2 of the Diabetes Dialogues podcast coming soon.
This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.
Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.
All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom ONE+, Dexcom Share, Share are trademark or registered trademarks in the U.S. and may be in other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom International, Ltd. and its affiliated European entities. 1 Tanfield, Suite 6, Level 1 Tanfield, Edinburgh EH3 5DA.
Further CPD accredited education can be found on the Dexcom Education Hub
